Denali Therapeutics Inc (DNLI) Dividend History

Denali Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing therapeutics for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.

Last update 05/10/2021


Dividend Yield Summary

  2016 2017 2018 2019 2020 2021
Dividends - - - - - -
Average Price - 17.97 18.51 19.71 33.88 64.15
Yield - - - - - -
• The above Dividend, Average Price, and Yield values for 2021 are year-to-date.

Dividend History

No history of dividends
Date Amount Per Share Note